Targeted GHRH Analogue (44 Amino Acids).
$150.00
Highly specific stimulation of somatotroph cellular pathways.
Observed elevation of IGF-1 expression in controlled models.
Aggressive, targeted modulation of deep visceral lipid stores.
Tesamorelin is a highly sophisticated, 44-amino-acid synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). It is explicitly utilized in advanced research to study the aggressive reduction of visceral adipose tissue. By signaling precise pituitary pathways in laboratory models, it commands the endogenous elevation of IGF-1, making it a top-tier compound for metabolic and lipid-targeting assays.
Visceral Lipid Selectivity:Unlike general metabolic agents, Tesamorelin demonstrates an extraordinary selectivity for deep, metabolic lipid stores in vitro. It allows researchers to study targeted fat oxidation pathways without the generalized degradation of surrounding structural mass.
Endogenous Pathway Optimization:Rather than overriding the system, Tesamorelin research focuses on the stimulation of natural, pulsatile growth hormone pathways. This provides a highly sustainable and naturalistic model for studying enhanced cellular recovery, IGF-1 optimization, and complete lipid profile overhaul.
Tesamorelin is not approved by the FDA, nor is it recognized as a prescription medication, dietary supplement, or therapeutic agent. It is strictly intended for research use only.